Evolent Health Stock Income Statements

Evolent Health Quarterly Income Statements Chart

Quarterly

Annual

Revenue

Gross Profit

Operating Profit

Net Income

Evolent Health Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2015-12-31

revenue	444,328,000	483,649,000	646,542,000	621,401,000	647,145,000	639,653,000	556,055,000	511,015,000	469,136,000	427,690,000	382,432,000	352,585,000	319,939,000	297,057,000
yoy	-31.34%	-24.39%	16.27%	21.60%	37.94%	49.56%	45.40%	44.93%	46.63%	43.98%
qoq	-8.13%	-25.19%	4.05%	-3.98%	1.17%	15.03%	8.81%	8.93%	9.69%	11.83%	8.47%	10.20%	7.70%
expenses
cost of revenue	343,943,000	381,178,000	570,831,000	540,708,000	540,302,000	535,547,000	454,428,000	386,585,000	351,938,000	310,475,000	299,368,000	266,617,000	249,705,000	219,739,000	164,480,000	163,126,000	172,113,000	157,832,000	176,743,000	183,165,000	165,812,000	175,653,000
gross profit	100,385,000	102,471,000	75,711,000	80,693,000	106,843,000	104,106,000	101,627,000	124,430,000	117,198,000	117,215,000	83,064,000	85,968,000	70,234,000	77,318,000
yoy	-6.04%	-1.57%	-25.50%	-35.15%	-8.84%	-11.18%	22.35%	44.74%	66.87%	51.60%
qoq	-2.04%	35.34%	-6.17%	-24.48%	2.63%	2.44%	-18.33%	6.17%	-0.01%	41.11%	-3.38%	22.40%	-9.16%
gross margin %	22.59%	21.19%	11.71%	12.99%	16.51%	16.28%	18.28%	24.35%	24.98%	27.41%	21.72%	24.38%	21.95%	26.03%
selling, general and administrative expenses	75,209,000	78,409,000	47,701,000	67,060,000	69,185,000	79,104,000	81,428,000	96,567,000	90,389,000	89,726,000	82,861,000	68,521,000	58,955,000	58,932,000	66,917,000	51,292,000	42,699,000	58,591,000	61,633,000	55,758,000	50,511,000	54,698,000	198,238,000	58,808,000	66,932,000	74,838,000	175,852,000	59,566,000	57,403,000	55,526,000	159,836,000	45,834,000	51,090,000	53,550,000	122,294,000	38,398,000	32,756,000
depreciation and amortization expenses	23,141,000	24,058,000	29,296,000	29,701,000	29,870,000	29,503,000	29,602,000	32,404,000	32,134,000	29,275,000	19,781,000	17,196,000	15,112,000	15,106,000	15,075,000	14,859,000	14,916,000	15,187,000	14,865,000	14,694,000	15,778,000	16,138,000	45,505,000	15,408,000	15,292,000	14,266,000	34,163,000	10,352,000	10,034,000	9,496,000	24,651,000	7,717,000	6,904,000	6,615,000	13,478,000	3,746,000	3,612,000
loss on lease termination		1,906,000
change in fair value of contingent consideration	3,206,000	-280,000	-4,200,000	200,000		8,908,000	5,937,000	11,300,000	-7,822,000	8,569,000	-17,700,000	-12,700,000	800,000	6,078,000												100,000
total operating expenses	445,499,000	485,271,000	665,138,000	637,669,000	639,357,000	653,062,000	577,405,000	528,953,000	490,704,000	438,045,000	384,310,000	339,634,000	324,572,000	299,855,000	260,572,000	229,052,000	229,728,000	231,016,000	271,870,000	282,301,000	466,101,000	272,785,000	912,714,000	240,281,000	217,192,000	244,402,000	513,566,000	160,977,000	153,264,000	153,846,000	385,858,000	121,932,000	126,188,000	127,693,000	415,558,000	76,049,000	69,147,000
operating income	-1,171,000	-1,622,000	-18,596,000	-16,268,000	7,788,000	-13,409,000	-21,350,000	-17,938,000	-21,568,000	-10,355,000	-1,878,000	12,951,000	-4,633,000	-2,798,000	-12,214,000	-6,581,000	-7,671,000	-15,945,000	53,000	-17,708,000	-227,469,000	-25,500,000	-286,474,000	-20,138,000	-25,233,000	-46,646,000	-36,450,000	-11,030,000	-8,966,000	-14,132,000	-58,820,000	-14,020,000	-19,117,000	-21,455,000	-221,580,000	-15,839,000	-12,629,000
yoy	-115.04%	-87.90%	-12.90%	-9.31%	-136.11%	29.49%	1036.85%	-238.51%	365.53%	270.09%	-84.62%	-296.79%	-39.60%	-82.45%	-23145.28%	-62.84%	-96.63%	-37.47%	-100.02%	-12.07%	801.47%	-45.33%	685.94%	82.57%	181.43%	230.07%	-38.03%	-21.33%	-53.10%	-34.13%	-73.45%	-11.48%	51.37%
qoq	-27.81%	-91.28%	14.31%	-308.89%	-158.08%	-37.19%	19.02%	-16.83%	108.29%	451.38%	-114.50%	-379.54%	65.58%	-77.09%	85.59%	-14.21%	-51.89%	-30184.91%	-100.30%	-92.22%	792.04%	-91.10%	1322.55%	-20.19%	-45.91%	27.97%	230.46%	23.02%	-36.56%	-75.97%	319.54%	-26.66%	-10.90%	-90.32%	1298.95%	25.42%
operating margin %	-0.26%	-0.34%	-2.88%	-2.62%	1.20%	-2.10%	-3.84%	-3.51%	-4.60%	-2.42%	-0.49%	3.67%	-1.45%	-0.94%
interest income	1,084,000	1,274,000	830,000	794,000	1,370,000	2,550,000	2,521,000	1,071,000	604,000	1,060,000	604,000	425,000	223,000	117,000	96,000	120,000	68,000	123,000	115,000	1,288,000	842,000	919,000	2,863,000	1,124,000	842,000	1,060,000	2,472,000	968,000	878,000	1,072,000	1,245,000	411,000	218,000	185,000	468,000	255,000	272,000
interest expense	-11,601,000	-10,385,000	-6,720,000	-6,010,000	-5,995,000	-5,997,000	-12,238,000	-14,614,000	-14,458,000	-12,895,000	-6,429,000	-4,754,000	-2,148,000	-2,241,000	-6,447,000	-6,367,000	-6,274,000	-6,337,000	-8,340,000	-7,419,000	-6,293,000	-6,285,000	-10,904,000	-3,630,000	-3,620,000	-3,562,000	-4,631,000	-853,000	-855,000	-853,000	-2,756,000	-880,000	-947,000	-954,000
gain from equity method investees	197,000	-19,000	182,000	-2,229,000	-1,700,000	306,000	28,000	684,000	155,000	423,000	629,000	1,392,000	1,952,000	596,000	454,000	63,000	4,879,000	7,783,000	-975,000	-13,717,000	25,143,000
extinguishment of series a preferred stock	-9,000,000
loss on option exercise	-196,000	-52,348,000
change in tax receivables agreement liability						-173,000	4,202,000
other income	-35,000	-48,000	381,000	-43,000	-105,000	8,000	-220,000	-77,000	-26,000	-220,000	-73,000	-345,000	297,000	178,000	-73,000	-41,000	-18,000	-14,000	-289,000	-111,000	352,000	-71,000	-408,000	-84,000	-587,000	427,000	233,000	-124,000	78,000	-18,000	156,000	15,000	3,000	2,000	3,000	1,000	1,000
income before income taxes	-20,722,000	-63,148,000	-23,923,000	-23,756,000	1,358,000	-16,715,000	-48,067,000	-30,874,000	-35,293,000	-88,171,000
benefit from income taxes	-825,000	1,470,000	-1,121,000	-619,000	-238,000	565,000	-14,656,000	-5,550,000	-970,000	-68,189,000	1,122,000	-45,516,000	-184,000	1,202,000				611,000
income before preferred dividends and accretion of series a preferred stock	-19,897,000	-64,618,000	-22,802,000	-23,137,000	1,596,000	-17,280,000	-33,411,000	-25,324,000	-34,323,000	-19,982,000
dividends and accretion of series a preferred stock	-31,193,000	-7,632,000	-7,813,000	-8,094,000	-7,979,000	-7,945,000	-7,984,000	-7,872,000	-7,088,000	-6,276,000
net income attributable to common shareholders of evolent health, inc.	-51,090,000	-72,250,000	-30,615,000	-31,231,000	-6,383,000	-25,225,000	-41,395,000	-33,196,000	-41,411,000	-26,258,000	-11,349,000	2,123,000	-4,588,000	-5,350,000	-5,647,000	-13,040,000	-9,107,000	-9,807,000	-14,625,000	-37,348,000	-203,521,000	-78,752,000
loss per common share
basic and diluted	-440	-630	-260	-270	-60	-220				-240									-70	-440	-2,380	-930
weighted-average common shares outstanding
basic and diluted	115,882,000	115,315,000	114,682,000	114,862,000	114,688,000	114,141,000	111,251		111,278,000	107,783,000	93,699		90,071	89,509	86,067	85,800	85,448	84,670	84,928,000	85,172,000	85,349,000	84,793,000	82,364,000	83,819,000	82,289,000	79,335,000	77,338,000
comprehensive loss
other comprehensive loss, net of taxes, related to:
foreign currency translation adjustment	22,000	24,000	-386,000	-12,000	-47,000	-51,000	8	-151	8,000	56,000	-134	-262	-288	-132	1	4	-58	-31	42,000	71,000	-4,000	-153,000	16,000	-68,000	11,000	24,000	-66,000	-116,000	-148,000
total comprehensive loss attributable to common shareholders of evolent health, inc.	-51,068,000	-72,226,000	-31,001,000	-31,243,000	-6,430,000	-25,276,000			-41,403,000	-26,202,000			-4,876	-5,482	-5,646	-13,036	-9,165	-9,838	-14,583,000	-37,277,000	-203,525,000	-78,905,000
loss on disposal of non-strategic assets
right-of-use assets impairment									24,065,000
loss on disposal of assets							524,250	2,097,000														6,447,000
loss on repayment on long-term debt
income from continuing operations							-33,411,000	-25,324,000	-34,323,000		-11,349,000	2,123,000	-4,125,000	-5,350,000	3,053,000	-13,040,000	-9,107,000	-11,190,000
income from discontinued operations, net of tax													-463,000		-8,700,000
income per common share
basic:
continuing operations							-370	-300	-370		-120	20	-50	-60	40	-150	-110	-130
discontinued operations											-2.5				-110			10
basic income per share attributable to common shareholders of evolent health, inc.							-0.228	-0.3			-0.023	0.02
diluted:
diluted income per share attributable to common shareholders of evolent health, inc.							-0.228	-0.3			-0.023	0.02
weighted-average common shares outstanding
basic								112,282				95,286																77,999,000	77,209,000	75,375,000	64,351,000	70,328,000	59,478,000	52,599,000	45,031,000	43,110,000	42,594,000
diluted								112,282				99,308																77,999,000	77,209,000	75,375,000	64,351,000	70,328,000	59,478,000	52,599,000	45,031,000	43,110,000	42,594,000
comprehensive income
other comprehensive income, net of taxes, related to:
total comprehensive income attributable to common shareholders of evolent health, inc.							-25,238	-33,347			-2,124.25	1,861
change in tax receivable agreement liability										-66,184,000	-3,080,000	-42,870,000
loss per common share
basic and diluted:
discontinued operations											-2.5				-110			10
basic and diluted									-370
net income										-26,258,000	-11,349	2,123	-4,588	-5,350	-5,647,000	-13,040,000	-9,107,000	-9,807,000	-13,803,000	-38,170,000	-203,521,000	-78,752,000	-279,842,000	-25,738,000	-31,900,000	-48,649,000	-41,636,000	-12,555,000	-10,031,000	-14,065,000	-56,638,000	-13,129,000	-19,698,000	-23,149,000	-211,003,000	-15,775,000	-11,999,000
yoy										490703.74%	-99.80%	-100.02%	-99.95%	-99.95%	-59.09%	-65.84%	-95.53%	-87.55%	-95.07%	48.30%	538.00%	61.88%	572.12%	105.00%	218.01%	245.89%	-26.49%	-4.37%	-49.08%	-39.24%	-73.16%	-16.77%	64.16%
qoq										231268.40%	-634.57%	-146.27%	-14.24%	-99.91%	-56.69%	43.19%	-7.14%	-28.95%	-63.84%	-81.25%	158.43%	-71.86%	987.27%	-19.32%	-34.43%	16.84%	231.63%	25.16%	-28.68%	-75.17%	331.40%	-33.35%	-14.91%	-89.03%	1237.58%	31.47%
net income margin %	0%	0%	0%	0%	0%	0%	0%	0%	0%	-6.14%	-0.00%	0.00%	-0.00%	-0.00%
gain on transfer of membership															22,969,000			22,969,000
loss on extinguishment/repayment of debt												-10,192,000
income from continuing operations before income taxes											-10,227,000	-43,393,000	-4,309,000	-4,148,000	2,600,000	-12,806,000	-9,016,000	-10,579,000
loss on repayment of debt															-2,185,000			-19,158,000
basic and diluted loss per share attributable to common shareholders of evolent health, inc.													-0.05	-0.06	-0.07	-0.15	-0.11	-0.12
transformation services															6,220,000	2,075,000	2,564,000	345,000	1,190,000	4,807,000	755,000	5,238,000	10,019,000	5,184,000	1,944,000	3,353,000	23,686,000	9,230,000	8,215,000	6,505,000
platform and operations services															242,138,000	220,396,000	219,493,000	214,726,000	240,492,000	230,299,000	212,375,000	209,900,000	488,000,000	171,438,000	144,522,000	147,292,000	382,096,000	118,094,000	113,346,000	109,818,000
total revenue															248,358,000	222,471,000	222,057,000	215,071,000	271,923,000	264,593,000	238,632,000	247,285,000	626,240,000	220,143,000	191,959,000	197,756,000	477,116,000	149,947,000	144,298,000	139,714,000	327,038,000	107,912,000	107,071,000	106,238,000	193,978,000	60,210,000	56,518,000
loss on extinguishment of debt																			-9,578,000	4,789,000
goodwill impairment																					215,100,000
change in fair value of contingent consideration and indemnification asset															14,100,000	-225,000		-594,000	4,352,000	2,570,000	756,000	-3,818,000	-3,497,000	-500,000	100,000		-4,204,000	100,000	-1,604,000
impairment of equity method investments																						-47,133,000
benefit for income taxes															-453,000	234,000	91,000		-422,000	503,000	-3,904,000	270,000	-20,687,000	-849,000	1,398,000	-496,000	-95,000	135,000	-109,000	3,000	-4,923,000	-1,714,000	-700,000	405,000	-10,499,000	-256,000	-371,000
net income attributable to non-controlling interests																			-205,500	-822,000			-3,392,000	-217,000	-285,000	-1,910,000	-1,407,000	-126,000	-115,000	-439,000	-8,561,000	-541,000	-2,793,000	-5,137,000	-62,469,000	-4,567,000	-3,612,000
total comprehensive loss															-5,646	-13,036	-9,165	-9,838	-13,761,000	-38,099,000	-203,525,000	-78,905,000
total comprehensive loss attributable to non-controlling interests																			-205,500	-822,000
gain from discontinued operations, net of tax																		1,383,000
premiums																			30,241,000	29,487,000	25,502,000	32,147,000	128,221,000	43,521,000	45,493,000	47,111,000	71,334,000	22,623,000	22,737,000	23,391,000
claims expenses																			24,815,000	21,325,000	18,144,000	23,667,000	100,972,000	34,802,000	36,085,000	37,757,000	53,897,000	16,992,000	18,428,000	16,749,000
(gain) loss on disposal of assets																			1,611,750						-9,600,000
income before income taxes and non-controlling interests																			-14,225,000	-37,667,000	-207,425,000	-78,482,000	-300,529,000	-26,587,000	-30,502,000	-49,145,000	-41,731,000	-12,420,000	-10,140,000	-14,062,000	-61,561,000	-14,843,000	-20,398,000	-22,744,000	-221,502,000	-16,031,000	-12,370,000
income from equity method investees																						-412,000	-5,606,000	-3,859,000	-1,904,000	-424,000	-3,355,000	-1,381,000
cost of revenue (exclusive of depreciation and amortization
expenses presented separately below)																							32,940,750	131,763,000	108,383,000	117,441,000	253,858,000	73,967,000	69,003,000	71,975,000	201,071,000	68,281,000	67,994,000	67,528,000	121,272,000	33,905,000	32,779,000
net income attributable to evolent health, inc.																							-6,380,250	-25,521,000	-31,615,000	-46,739,000	-40,229,000	-12,429,000	-9,916,000	-13,626,000	-48,077,000	-12,588,000	-16,905,000	-18,012,000	-148,534,000	-11,208,000	-8,387,000
earnings available for common shareholders
basic and diluted																							-6,380,250	-25,521,000	-31,615,000	-46,739,000
earnings per common share
basic and diluted																							-75	-300	-380	-590
total comprehensive income																							-6,451,500	-25,806,000	-31,889,000	-48,625,000	-41,702,000	-12,671,000	-10,179,000	-14,065,000
total comprehensive income attributable to non-controlling interests																							-54,250	-217,000	-285,000	-1,910,000	-1,407,000	-126,000	-115,000	-439,000
total comprehensive income attributable to evolent health, inc.																							-6,397,250	-25,589,000	-31,604,000	-46,715,000	-40,295,000	-12,545,000	-10,064,000	-13,626,000
earnings available for common shareholders
basic																											-3,107,250	-12,429,000	-9,916,000	-13,626,000	-48,077,000	-12,588,000	-16,905,000	-18,012,000	-148,534,000	-11,208,000	-8,387,000
diluted																											-3,107,250	-12,429,000	-9,916,000	-13,626,000	-48,077,000	-12,588,000	-16,905,000	-18,012,000	-148,534,000	-11,208,000	-8,387,000
earnings per common share
basic																											-40	-160	-130	-180	-760	-180	-280	-340	-3,290	-260	-200
diluted																											-40	-160	-130	-180	-760	-180	-280	-340	-3,290	-260	-200
income from equity affiliates																													-1,275,000
loss on change in fair value of contingent consideration																														100,000	25,000	100,000	200,000
income from affiliates																														-131,000	-92,250	-369,000	-555,000	-522,000	-393,000	-448,000	-14,000
transformation																															21,262,000	8,204,000	5,361,000	10,235,000	30,563,000	7,757,000	10,388,000
platform and operations																															305,776,000	99,708,000	101,710,000	96,003,000	163,415,000	52,453,000	46,130,000
gain on consolidation

We provide you with 20 years income statements for Evolent Health stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Evolent Health stock. Explore the full financial landscape of Evolent Health stock with our expertly curated income statements.

The information provided in this report about Evolent Health stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.